BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29254223)

  • 1. Development and validation of a targeted next generation DNA sequencing panel outperforming whole exome sequencing for the identification of clinically relevant genetic variants.
    Miller EM; Patterson NE; Zechmeister JM; Bejerano-Sagie M; Delio M; Patel K; Ravi N; Quispe-Tintaya W; Maslov A; Simmons N; Castaldi M; Vijg J; Karabakhtsian RG; Greally JM; Kuo DYS; Montagna C
    Oncotarget; 2017 Nov; 8(60):102033-102045. PubMed ID: 29254223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein-Coding Regions.
    Lelieveld SH; Spielmann M; Mundlos S; Veltman JA; Gilissen C
    Hum Mutat; 2015 Aug; 36(8):815-22. PubMed ID: 25973577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation diagnostics: gene panel, exome, or whole genome?
    Sun Y; Ruivenkamp CA; Hoffer MJ; Vrijenhoek T; Kriek M; van Asperen CJ; den Dunnen JT; Santen GW
    Hum Mutat; 2015 Jun; 36(6):648-55. PubMed ID: 25772376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurology Individualized Medicine: When to Use Next-Generation Sequencing Panels.
    Klein CJ; Foroud TM
    Mayo Clin Proc; 2017 Feb; 92(2):292-305. PubMed ID: 28160876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications and analysis of targeted genomic sequencing in cancer studies.
    Bewicke-Copley F; Arjun Kumar E; Palladino G; Korfi K; Wang J
    Comput Struct Biotechnol J; 2019; 17():1348-1359. PubMed ID: 31762958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data.
    Cherukuri PF; Maduro V; Fuentes-Fajardo KV; Lam K; ; Adams DR; Tifft CJ; Mullikin JC; Gahl WA; Boerkoel CF
    BMC Genomics; 2015 Nov; 16():998. PubMed ID: 26602380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
    Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
    Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies.
    Chou J; Ohsumi TK; Geha RS
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):623-8. PubMed ID: 23095910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational pharmacogenotype extraction from clinical next-generation sequencing.
    Shugg T; Ly RC; Osei W; Rowe EJ; Granfield CA; Lynnes TC; Medeiros EB; Hodge JC; Breman AM; Schneider BP; Sahinalp SC; Numanagić I; Salisbury BA; Bray SM; Ratcliff R; Skaar TC
    Front Oncol; 2023; 13():1199741. PubMed ID: 37469403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing INDEL calling errors in whole genome and exome sequencing data.
    Fang H; Wu Y; Narzisi G; O'Rawe JA; Barrón LT; Rosenbaum J; Ronemus M; Iossifov I; Schatz MC; Lyon GJ
    Genome Med; 2014; 6(10):89. PubMed ID: 25426171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do second generation sequencing techniques identify documented genetic markers for neonatal diabetes mellitus?
    Ali Khan I
    Heliyon; 2021 Sep; 7(9):e07903. PubMed ID: 34584998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Next-Generation Sequencing in Pharmacogenomics.
    Enko D; Michaelis S; Schneider C; Schaflinger E; Baranyi A; Schnedl WJ; Muller DJ
    Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostics of Primary Immunodeficiencies through Next-Generation Sequencing.
    Gallo V; Dotta L; Giardino G; Cirillo E; Lougaris V; D'Assante R; Prandini A; Consolini R; Farrow EG; Thiffault I; Saunders CJ; Leonardi A; Plebani A; Badolato R; Pignata C
    Front Immunol; 2016; 7():466. PubMed ID: 27872624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing.
    van Nimwegen KJ; van Soest RA; Veltman JA; Nelen MR; van der Wilt GJ; Vissers LE; Grutters JP
    Clin Chem; 2016 Nov; 62(11):1458-1464. PubMed ID: 27630156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
    O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
    Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.